pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Preclinical
NouvSight-001
Diabetic Retinopathy
iRegene Therapeutics Co Ltd
0
catalysts
Phase 2
Nov-DB2
Obesity
NovMetaPharma Co Ltd
0
catalysts
Preclinical
NovAD
Alzheimer's Disease
NovMetaPharma Co Ltd
0
catalysts
Phase 2
NovOB
Obesity
DNA gyrase
← prev
page 134 of 271
next →
131
Pain
89
Neurology
1
NovMetaPharma Co Ltd
0
catalysts
Preclinical
Novel Drug to Undisclosed Target
Crohn's Disease (Regional Enteritis)
$VIVS
VivoSim Labs, INC.
0
catalysts
Preclinical
Novel Molecules for Glioma
Glioma
$MRK
Merck & Co., Inc.
0
catalysts
Preclinical
Novel Therapeutic
Glioblastoma Multiforme (GBM)
Rosalind Franklin University of Medicine and Science
0
catalysts
Phase 2
NovoCardia
Congestive Heart Failure (Heart Failure)
Help Therapeutics
0
catalysts
Phase 2
Nu-3
Diabetic Foot Ulcers
Lakewood-Amedex Inc
0
catalysts
Phase 2
NuGel
Atopic Dermatitis (Atopic Eczema)
Hudson Therapeutics Inc
0
catalysts
Preclinical
Nubytide
Alzheimer's Disease
Cenna Biosciences Inc
0
catalysts
Marketed
Nuprin
Motrin IB (ibuprofen)
Primary Dysmenorrhea
$KVUE
Kenvue Inc.
0
catalysts
Marketed
Nuvigil
Armodafinil Sandoz (armodafinil)
Narcolepsy
Sandoz Inc
0
catalysts
Preclinical
NvA-011
Dystrophic Epidermolysis Bullosa
Nova Anchora LLC
0
catalysts
Phase 2
OA-SYS
Osteoarthritis
Ageless Biotech Inc
0
catalysts
Phase 2
OATD-01
Pulmonary Sarcoidosis
Molecure SA
0
catalysts
Phase 2
OBI-902
Bile Duct Cancer (Cholangiocarcinoma)
OBI Pharma Inc
0
catalysts
Phase 2
OBX-115
Metastatic Melanoma
Obsidian Therapeutics Inc
0
catalysts
Phase 1
OCF-001
Vulvovaginal Candidiasis
Sano Chemicals Inc
0
catalysts
Preclinical
OCF-203
Idiopathic Pulmonary Fibrosis
$OCEA
Ocean Biomedical, Inc.
0
catalysts
Preclinical
OCT-130401
Trigeminal Neuralgia (Tic Douloureux)
Oxford Cannabinoid Technologies Ltd
0
catalysts
Phase 1
OCU-200
Diabetic Macular Edema
$OCGN
Ocugen, Inc.
0
catalysts
Phase 2
OCU-410
Geographic Atrophy
$OCGN
Ocugen, Inc.
0
catalysts
Phase 3
OCU-410ST
Juvenile Macular Degeneration (Stargardt Disease)
$OCGN
Ocugen, Inc.
0
catalysts
Preclinical
OCU-510
Seasonal Influenza
$OCGN
Ocugen, Inc.
0
catalysts
Preclinical
OCU-520
Coronavirus Disease 2019 (COVID-19)
$OCGN
Ocugen, Inc.
0
catalysts
Preclinical
OCX-410
Non-Small Cell Lung Carcinoma
$OCEA
Ocean Biomedical, Inc.
0
catalysts
Preclinical
OCX-909
Glioblastoma Multiforme (GBM)
$OCEA
Ocean Biomedical, Inc.
0
catalysts
Preclinical
OFXO-11
Osteoporosis
OssiFi Inc
0
catalysts
OGIVRI
OGIVRI (TRASTUZUMAB-DKST)
MYLAN GMBH
0
catalysts
